Overview
- 6 inspections across 6 sites are on record.
- 6 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-08-23.
At a glance
Inspections
6
Sites
6
Observations
6
Career since
Nov 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 23 Aug 2024 | Biologics | View 483 → |
| Octapharma AB | 19 Sep 2023 | Biologics | View 483 → |
| Kamada - Production Plant | 2 Mar 2023 | Biologics | On file |
| Grifols Biologicals LLC | 12 Sep 2019 | Biologics | On file |
| Grifols Biologicals LLC | 12 Sep 2019 | Biologics | On file |
Sites inspected
Merck Sharp & Dohme LLCWest Point, United States1 insp.
Octapharma ABStockholm, Sweden1 insp.
Kamada - Production PlantMP Negev, Israel1 insp.
Grifols Biologicals LLCCity Of Industry, United States1 insp.
Grifols Biologicals LLCLos Angeles, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nobuko H Katagiri2 shared
Malgorzata G Norton2 shared
Vijaya L Simhadri2 shared
Decarlos A Gomez2 shared
Omotunde O Osunsanmi2 shared
Unnee Ranjan1 shared
Travis S Bradley1 shared
Alan L Truong1 shared
Prajakta A Varadkar1 shared
Ze Peng1 shared
Full investigator report
Get the verbatim findings behind Olga Simakova's 6 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site